These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 864758)

  • 1. Immune response to L2 guinea pig leukemia-specific antigens.
    Murphy SG; Laufman H; LoBuglio AF
    J Natl Cancer Inst; 1977 Jun; 58(6):1815-8. PubMed ID: 864758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor immunity in strain 2 guinea pigs immunized with potassium chloride extracts of L2C tumor cells.
    Braun DP; Hengst JC; Mokyr MB; Dray S
    J Natl Cancer Inst; 1978 Apr; 60(4):899-903. PubMed ID: 344900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant lines of guinea pig L2C leukemia. I. Deletion of Ia alloantigens is associated with a loss in immunogenicity of tumor-associated transplantation antigens.
    Forni G; Shevach EM; Green I
    J Exp Med; 1976 May; 143(5):1067-81. PubMed ID: 1262783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attempt to immunize guinea pigs against L2C leukemia with leukemia cells inactivated by gamma irradiation.
    Gross L; Dreyfuss Y
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3495-8. PubMed ID: 291016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of syngeneic tumour-specific immunity by liposomes reconstituted with L2C tumour-cell antigens.
    Schroit AJ; Key ME
    Immunology; 1983 Jul; 49(3):431-8. PubMed ID: 6862519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L2C guinea pig leukemia: immunoprotection and immunotherapy.
    Ellman L; Green I
    Cancer; 1971 Sep; 28(3):647-54. PubMed ID: 4328921
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune response in strain 2 guinea pigs to the syngeneic L2C leukemia.
    Ricardo MJ; Grimm DT
    Adv Exp Med Biol; 1983; 166():67-78. PubMed ID: 6359830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant lines of guinea pig L2C leukemia. II. Comparative cytogenetic studies and banding analyses of normal and leukemic karyotypes.
    Whang-Peng J; Lee EC; Forni G; Green I
    J Natl Cancer Inst; 1976 Oct; 57(4):897-905. PubMed ID: 1034020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a tumor-associated antigen of the guinea pig L2C leukemia by using syngeneic antisera.
    Hu CP; Schwartz BD; Green I
    J Immunol; 1978 Feb; 120(2):597-601. PubMed ID: 74393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization and partial characterization of a tumor-associated transplantation antigen of the guinea pig L2C leukemia.
    Hu CP; Konen TG; Hoes C; Green I
    J Immunol; 1978 May; 120(5):1521-5. PubMed ID: 77874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L2C guinea pig leukemia. A potential model for structuring multimodality therapy.
    Murphy S
    Isr J Med Sci; 1978 Jan; 14(1):20-37. PubMed ID: 632081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attempt to immunize guinea pigs against leukemia by skin scarification with leukemic cell suspensions.
    Gross L
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3432-6. PubMed ID: 4519636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and immunosensitivity of a guinea pig B-cell leukemia subline lacking cell surface Ia antigens.
    Tanio Y; Zbar B
    Cancer Res; 1985 Jan; 45(1):143-8. PubMed ID: 3917369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG-immunotherapy of L2C guinea pig leukemia.
    Dopatka HD; Majer M; Freudenstein H; Hennessen W
    Dev Biol Stand; 1977 Apr 13-15; 38():355-8. PubMed ID: 608523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological studies of the guinea pig L2C leukemia.
    Green I; Forni G; Konen T; Hu CP; Schwartz BD; Kask A; Shevach EM
    Fed Proc; 1977 Aug; 36(9):2264-7. PubMed ID: 328308
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro cytotoxic effect of guinea-pig natural killer cells (Kurloff cells) on homologous leukemic cells (L2C).
    Debout C; Birebent B; Griveau AM; Izard J
    Leukemia; 1993 May; 7(5):733-5. PubMed ID: 8483326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant lines of guinea pig L2C leukemia. III. The reaction of an alloantiserum detecting idiotypic determinants on a clonally derived guinea pig B cell leukemia with IgM and Ia molecules.
    Konen TG; Green I; Shevach EM; Kask AM; Schwartz BD
    J Immunol; 1976 Nov; 117(5 Pt.2):1966-70. PubMed ID: 62799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia.
    Gregg EO; Bridges SH; Youle RJ; Longo DL; Houston LL; Glennie MJ; Stevenson FK; Green I
    J Immunol; 1987 Jun; 138(12):4502-8. PubMed ID: 3495593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the skin in active specific immunization against leukemia in guinea pigs.
    Gross L; Dreyfuss Y
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3550-4. PubMed ID: 4139717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guinea pig leukemia L2C: characterization of chromosomes and attempts to demonstrate antigenicity.
    Wepsic HT; Zbar B; Whang-Peng J; Borsos T; Rapp HJ
    J Natl Cancer Inst; 1970 Jul; 45(1):99-105. PubMed ID: 5449215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.